Calcific Aortic Valve Disease

Calcific Aortic Valve Disease (CAVD) stands as a progressive cardiovascular condition marked by the gradual buildup of calcium deposits on the aortic valve. This ailment, while commonly associated with the aging population, can manifest in younger individuals with specific risk factors. The accumulation of calcium on the valve leaflets leads to a consequential thickening and rigidity, impairing the valve's normal functionality. As CAVD progresses, individuals may experience symptoms such as chest pain, fatigue, and shortness of breath. The intricate interplay of genetic predisposition, age-related degeneration, and cardiovascular risk factors contribute to the development of CAVD. Timely diagnosis, often facilitated by echocardiography, plays a pivotal role in managing this condition effectively. Treatment modalities span lifestyle adjustments and pharmaceutical interventions to surgical procedures, aiming to alleviate symptoms and enhance overall cardiac function. Continuous research endeavors in this field strive to deepen our comprehension of CAVD mechanisms, laying the foundation for innovative therapeutic approaches and preventive strategies. Given the global impact of CAVD on cardiovascular health, fostering awareness about risk factors and advocating for early intervention remains crucial for improving patient outcomes and mitigating the burden of this prevalent cardiac disorder.